First in Human Study of QLS5316 in Solid Tumors

Clinical trial NCT07358884 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07358884
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors Colorectal Cancer Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Head and Neck Squamous Cell Carcinoma Non-small Cell Lung Cancer

Start date: 2026-01-01
Primary completion: 2027-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.